Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eledon Pharmaceuticals, Inc.

2.87
-0.0200-0.69%
Post-market: 2.870.00000.00%16:05 EDT
Volume:191.52K
Turnover:560.34K
Market Cap:171.86M
PE:-3.85
High:3.09
Open:3.00
Low:2.86
Close:2.89
Loading ...
Mar 15, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 07, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 28, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 17, 2020

Correspondence

CORRESP [Cover] - Correspondence
Dec 10, 2020

Major Issues Report

8-K - Current report
Dec 04, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 20, 2020

Major Issues Report

8-K/A [Amend] - Current report
Nov 20, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 20, 2020

Major Issues Report

8-K - Current report
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]